Literature DB >> 10229642

Correlation of aqueous and lipid solubilities with flux for prodrugs of 5-fluorouracil, theophylline, and 6-mercaptopurine: A Potts-Guy approach.

W J Roberts1, K B Sloan.   

Abstract

The Potts and Guy equation that has been used to predict permeability coefficients for molecules being delivered from aqueous vehicles has been transformed to accommodate lipid vehicles that are less polar than skin, and polar vehicles that are less polar than water. Solubilities in pH 4.0 aqueous buffer (SAQ), solubilities in isopropyl myristate (SIPM), and molecular weights (MW) of prodrugs of 5-fluorouracil (5-FU), theophylline (Th), and 6-mercaptopurine (6-MP) have been regressed against their fluxes from suspensions in IPM (JM). Seven series (n = 39) of alkylcarbonyloxymethyl (ACOM), alkyloxycarbonyl (AOC), alkylcarbonyl (AC), and alkylaminocarbonyl (AAC) prodrugs were used to determine the best fit to the transformed Potts and Guy equation (eq 6): log JM = x + y log SIPM + (1 - y)log SAQ - z MW. The estimated values for x, y, and z were -0. 193, +0.525, and +0.00364, respectively, with r 2 = 0.945 for n = 39. Inclusion of a miscellaneous series comprised of the parent drugs and a branched alkyl chain prodrug gave an equally good fit only if 6-MP was excluded from the analysis. The best performer (largest JM) in each series was usually correctly identified. The values for x, y, and z were consistent with values obtained by Potts and Guy, but the inclusion of the (l - y)log SAQ term in eq 6 and the value for y, shows that water solubility is almost as important as lipid solubility in predicting flux. There were no significant changes in predicted log JM or xi for each series if their log JM or xi were calculated using y and z coefficients obtained for solutions to eq 6 from which the data for the series had been excluded. This suggests that the data from all the series is homogeneous. Data from Kasting, Smith, and Cooper for SIPM, SPG, and MW of unrelated molecules were regressed against their fluxes from propylene glycol (PG) using eq 7: log JM = x + y log SIPM + (1 - y) log SPG - z MW. The estimated values for x, y, and z were -1.673, +0.599, and +0.00595, respectively, with r 2 = 0.852 for n = 28. These values for x, y, and z are also consistent with those previously reported by Potts and Guy, and, together with the results for fluxes from IPM, show the general utility of the transformed Potts and Guy equation in predicting flux from vehicles other than water and in showing the importance of solubility in a polar solvent as well as a nonpolar solvent in predicting flux.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10229642     DOI: 10.1021/js980419b

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  13 in total

1.  Synthesis, in vitro skin permeation studies, and PLS-analysis of new naproxen derivatives.

Authors:  H Weber; U Steimer; R Mannhold; G Cruciani
Journal:  Pharm Res       Date:  2001-05       Impact factor: 4.200

2.  Prodrugs of theophylline incorporating ethyleneoxy groups in the promoiety: synthesis, characterization, and transdermal delivery.

Authors:  Susruta Majumdar; Maren Mueller-Spaeth; Kenneth B Sloan
Journal:  AAPS PharmSciTech       Date:  2012-05-31       Impact factor: 3.246

3.  Human skin permeation of branched-chain 3-0-alkyl ester and carbonate prodrugs of naltrexone.

Authors:  Haranath K Vaddi; Mohamed O Hamad; Jianhong Chen; Stan L Banks; Peter A Crooks; Audra L Stinchcomb
Journal:  Pharm Res       Date:  2005-05-17       Impact factor: 4.200

4.  Topical delivery of 5-fluorouracil and 6-mercaptopurine by their alkylcarbonyloxymethyl prodrugs from water: vehicle effects on design of prodrugs.

Authors:  Kenneth B Sloan; Scott Wasdo; Udo Ezike-Mkparu; Thomas Murray; Donna Nickels; Surjit Singh; Thea Shanks; John Tovar; Karen Ulmer; Robert Waranis
Journal:  Pharm Res       Date:  2003-04       Impact factor: 4.200

5.  Physicochemical evaluation, in vitro human skin diffusion, and concurrent biotransformation of 3-O-alkyl carbonate prodrugs of naltrexone.

Authors:  Omathanu Pillai; Mohamed O Hamad; Peter A Crooks; Audra L Stinchcomb
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

6.  5-Fluoro-1-(penta-noyl)pyrimidine-2,4(1H,3H)-dione.

Authors:  Hans-Joachim Lehmler; Sean Parkin
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-02-22

7.  Transdermal delivery of bupropion and its active metabolite, hydroxybupropion: a prodrug strategy as an alternative approach.

Authors:  Paul K Kiptoo; Kalpana S Paudel; Dana C Hammell; Raghotham Reddy Pinninti; Jianhong Chen; Peter A Crooks; Audra L Stinchcomb
Journal:  J Pharm Sci       Date:  2009-02       Impact factor: 3.534

8.  Topical delivery of a model phenolic drug: alkyloxycarbonyl prodrugs of acetaminophen.

Authors:  Scott C Wasdo; Kenneth B Sloan
Journal:  Pharm Res       Date:  2004-06       Impact factor: 4.200

Review 9.  Design for optimized topical delivery: Prodrugs and a paradigm change.

Authors:  Kenneth B Sloan; Scott C Wasdo; Jarkko Rautio
Journal:  Pharm Res       Date:  2006-11-16       Impact factor: 4.580

10.  5-Fluoro-1-(3-metylbutano-yl)pyrimidine-2,4(1H,3H)-dione.

Authors:  Hans-Joachim Lehmler; Sean Parkin
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.